Literature DB >> 27278683

Interaction of Citrus Juices with Cyclosporine: Systematic Review and Meta-Analysis.

Kannan Sridharan1, Gowri Sivaramakrishnan2.   

Abstract

INTRODUCTION: Cyclosporine is an immunosuppressant with narrow therapeutic window, metabolized mainly by cytochrome P450 3A4 (CYP3A4) and minimally by cytochrome P450 3A5 (CYP3A5). Citrus juices such as grapefruit juice (GFJ), orange, lemon, pomelo and lime were known to interact with cyclosporine in several randomized controlled trials. The present review is a systematic compilation and quantitative synthesis on the changes of cyclosporine pharmacokinetics with concomitant citrus juice administration.
METHODS: Electronic databases were searched for randomized controlled trials evaluating the effect of any citrus juice on the pharmacokinetics of cyclosporine comparing with water or placebo in healthy volunteers using appropriate search strategies. Percent mean difference with standard error was used to assess the magnitude of difference in the following outcome measures: area under curve from time of drug administration to 24 h (AUC0-24), area under curve from time of drug administration to infinity (AUC0-∞), maximum concentration (C max), time to achieve C max (T max), elimination half-life (T 1/2), clearance (CL), volume of distribution and frequency for adverse drug reactions following administration of cyclosporine. RevMan 5.3 software was used to assess heterogeneity (by I2 statistics), use random-effects model and generate pooled results and Forest plot.
RESULTS: A total of 57 studies were obtained with the search strategy, of which seven were found eligible to be included in the present review. The pooled percent mean difference [95 % CI] for GFJ in comparison to controls for AUC0-24, AUC0-∞, C max and T max of cyclosporine was observed to be 53 [43, 64], 53 [45, 62], 24 [12, 36] and 19 [12, 26], respectively. Similarly, pomelo juice was found to significantly increase both AUC0-∞ and C max with the pooled percent mean difference [95 % CI] as 23 [13, 32] and 25 [1, 50], respectively but decrease T 1/2 {-8 [-15, -1]} of cyclosporine. Orange juice did not alter any of the pharmacokinetic parameter of cyclosporine significantly.
CONCLUSION: Citrus juices especially GFJ and pomelo juice were found to significantly increase the plasma exposure of cyclosporine while orange juice did not exhibit any significant interaction with cyclosporine.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27278683     DOI: 10.1007/s13318-016-0351-4

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  27 in total

Review 1.  Potential risks resulting from fruit/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters.

Authors:  Lourdes Rodríguez-Fragoso; José Luis Martínez-Arismendi; Danae Orozco-Bustos; Jorge Reyes-Esparza; Eliseo Torres; Scott W Burchiel
Journal:  J Food Sci       Date:  2011-05       Impact factor: 3.167

Review 2.  What's the scoop with grapefruit?

Authors:  Emily S Sterling; Kelly M Smith
Journal:  Orthopedics       Date:  2005-01       Impact factor: 1.390

3.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  J Clin Epidemiol       Date:  2009-07-23       Impact factor: 6.437

4.  Pomelo enhances cyclosporine bioavailability in healthy male Thai volunteers.

Authors:  Wirin Anlamlert; Pakawadee Sermsappasuk; Dhirayudh Yokubol; Sirada Jones
Journal:  J Clin Pharmacol       Date:  2014-12-30       Impact factor: 3.126

5.  Effect of grapefruit juice on pharmacokinetics of microemulsion cyclosporine in African American subjects compared with Caucasian subjects: does ethnic difference matter?

Authors:  M Lee; D I Min; Y M Ku; M Flanigan
Journal:  J Clin Pharmacol       Date:  2001-03       Impact factor: 3.126

6.  Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine.

Authors:  K S Lown; R R Mayo; A B Leichtman; H L Hsiao; D K Turgeon; P Schmiedlin-Ren; M B Brown; W Guo; S J Rossi; L Z Benet; P B Watkins
Journal:  Clin Pharmacol Ther       Date:  1997-09       Impact factor: 6.875

7.  Fruit and vegetable intake among adolescents and adults in the United States: percentage meeting individualized recommendations.

Authors:  Joel Kimmons; Cathleen Gillespie; Jennifer Seymour; Mary Serdula; Heidi Michels Blanck
Journal:  Medscape J Med       Date:  2009-01-26

8.  Effect of grapefruit juice on blood cyclosporin concentration.

Authors:  G C Yee; D L Stanley; L J Pessa; T Dalla Costa; S E Beltz; J Ruiz; D T Lowenthal
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

9.  6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect.

Authors:  Shefali M Kakar; Mary F Paine; Paul W Stewart; Paul B Watkins
Journal:  Clin Pharmacol Ther       Date:  2004-06       Impact factor: 6.875

10.  Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study.

Authors:  Henrik Ekberg; Corrado Bernasconi; Jana Nöldeke; Alexander Yussim; Lars Mjörnstedt; Uģur Erken; Markus Ketteler; Pavel Navrátil
Journal:  Nephrol Dial Transplant       Date:  2010-01-26       Impact factor: 5.992

View more
  5 in total

Review 1.  Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance.

Authors:  K Simon Yeung; Marisol Hernandez; Jun J Mao; Ingrid Haviland; Jyothirmai Gubili
Journal:  Phytother Res       Date:  2018-02-21       Impact factor: 5.878

2.  Grapefruit: Some perspectives in pharmacology and nutrition.

Authors:  Sergei V Jargin
Journal:  J Intercult Ethnopharmacol       Date:  2017-05-30

Review 3.  Chemical and Biological Properties of S-1-Propenyl-l-Cysteine in Aged Garlic Extract.

Authors:  Yukihioro Kodera; Mitsuyasu Ushijima; Hirotaka Amano; Jun-Ichiro Suzuki; Toshiaki Matsutomo
Journal:  Molecules       Date:  2017-03-31       Impact factor: 4.411

4.  Chronic Use of Proton-Pump Inhibitors and Iron Status in Renal Transplant Recipients.

Authors:  Rianne M Douwes; António W Gomes-Neto; Michele F Eisenga; Joanna Sophia J Vinke; Martin H de Borst; Else van den Berg; Stefan P Berger; Daan J Touw; Eelko Hak; Hans Blokzijl; Gerjan Navis; Stephan J L Bakker
Journal:  J Clin Med       Date:  2019-09-03       Impact factor: 4.241

5.  Pharmacokinetic parameters of ifosfamide in mouse pre-administered with grapefruit juice or naringin.

Authors:  Eduardo Madrigal-Bujaidar; Edilberto Pérez-Montoya; Sandra García-Medina; José Melesio Cristóbal-Luna; José A Morales-González; Eduardo Osiris Madrigal-Santillán; Rogelio Paniagua-Pérez; Isela Álvarez-González
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.